Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 217S · 10 late217 trades$54.77M| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 21 | Eizen Joshua MSee Remarks |  ANTXAN2 Therapeutics, Inc.Open-market sale | SELL | $12K 2,826 sh | Nov 6, 2026 |
| 21 | Zeff Capital, LP10% Owner |  BUKSBUTLER NATIONAL CORPOpen-market sale | SELL | $29K 5,500 sh | Nov 6, 2026 traded Nov 4, 2026 |
| 21 | Jackson JamereCFO |  AZOAUTOZONE INCOpen-market sale | SELL | $9,900 3 sh | Nov 6, 2026 traded Nov 4, 2026 |
| 20 | Robinson ElliottDirector |  HNGEHinge Health, Inc.Open-market sale | SELL | — 0 sh | Nov 6, 2026 traded Nov 4, 2026 |
| 20 | Robinson ElliottDirector | HNGEHinge Health, Inc. Open-market sale | SELL | — 0 sh | Nov 6, 2026 traded Nov 4, 2026 |
| 20 | Robinson ElliottDirector | HNGEHinge Health, Inc. Open-market sale | SELL | — 0 sh | Nov 6, 2026 traded Nov 4, 2026 |
| 20 | Saba Capital Management, L.P.10% Owner |  ECATBlackRock ESG Capital Allocation Term TrustOpen-market sale | SELL | $466K 35.4K sh | Nov 6, 2026 traded Nov 5, 2026 |
| 20 | Debbi NirDirector, President |  GLBEGlobal-E Online Ltd.Open-market sale · 10b5-1 plan | SELL | $4.46M 100.0K sh | Nov 6, 2026 traded Nov 4, 2026 |
| 20 | Robinson ElliottDirector | HNGEHinge Health, Inc. Open-market sale | SELL | — 0 sh | Nov 6, 2026 traded Nov 4, 2026 |
| 20 | Saba Capital Management, L.P.10% Owner |  PDXPIMCO Dynamic Income Strategy FundOpen-market sale | SELL | $678K 32.7K sh | Nov 6, 2026 traded Nov 4, 2026 |
| 20 | Robinson ElliottDirector | HNGEHinge Health, Inc. Open-market sale | SELL | — 0 sh | Nov 6, 2026 traded Nov 4, 2026 |
| 20 | Robinson ElliottDirector | HNGEHinge Health, Inc. Open-market sale | SELL | — 0 sh | Nov 6, 2026 traded Nov 4, 2026 |
| 20 | Robinson ElliottDirector | HNGEHinge Health, Inc. Open-market sale | SELL | — 0 sh | Nov 6, 2026 traded Nov 4, 2026 |
| 20 | Robinson ElliottDirector | HNGEHinge Health, Inc. Open-market sale | SELL | — 0 sh | Nov 6, 2026 traded Nov 4, 2026 |
| 20 | Robinson ElliottDirector | HNGEHinge Health, Inc. Open-market sale | SELL | — 0 sh | Nov 6, 2026 traded Nov 4, 2026 |
| 20 | Gowans JasonEVP and CDTO |  LEVILEVI STRAUSS & COOpen-market sale | SELL | $83K 3,494 sh | Nov 6, 2026 traded Nov 4, 2026 |
| 19 | Patel Sanj KDirector, CHAIRMAN & CEO |  KNSAKiniksa Pharmaceuticals International, plcOpen-market sale · 10b5-1 plan | SELL | $1.06M 11.3K sh | Nov 6, 2026 traded Nov 4, 2026 |
| 19 | Hugh MiltonEVP, Sales |  VIKViking Holdings LtdOpen-market sale · 10b5-1 plan | SELL | $1.80M 20.0K sh | Nov 6, 2026 traded Nov 4, 2026 |
| 19 | King Ryan ADirector, Co-Founder |  CHYMChime Financial, Inc.Open-market sale · 10b5-1 plan | SELL | $1.85M 59.0K sh | Nov 6, 2026 traded Nov 5, 2026 |
| 19 | Ehrlichman MattDirector, CEO, CHAIRMAN AND FOUNDER, 10% Owner |  PRCHPorch Group, Inc.Open-market sale · 10b5-1 plan | SELL | $120K 5,701 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 19 | Goldberg ChenEVP, Product & Engineering | CRWVCoreWeave, Inc. Open-market sale | SELL | $32K 695 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 19 | Patel Sanj KDirector, CHAIRMAN & CEO | KNSAKiniksa Pharmaceuticals International, plc Open-market sale · 10b5-1 plan | SELL | $2.59M 26.9K sh | Nov 6, 2026 traded Nov 4, 2026 |
| 19 | Patel Sanj KDirector, CHAIRMAN & CEO | KNSAKiniksa Pharmaceuticals International, plc Open-market sale · 10b5-1 plan | SELL | $2.85M 29.8K sh | Nov 6, 2026 traded Nov 4, 2026 |
| 18 | Kansal MohitChief Payments Officer |  FLYWFlywire CorpOpen-market sale · 10b5-1 plan | SELL | $127K 6,053 sh | Nov 6, 2026 traded Nov 4, 2026 |
| 18 | BENJAMIN C SINGERChief Legal Officer; Secretary |  PCORPROCORE TECHNOLOGIES, INC.Open-market sale · 10b5-1 plan | SELL | $194K 2,586 sh | Nov 6, 2026 traded Nov 4, 2026 |
| 18 | Zerbe Robert L MdDirector |  VCELVericel CorpOpen-market sale · 10b5-1 plan | SELL | $129K 2,500 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 18 | DIRK VAN DE PUTDirector, Chief Executive Officer |  MDLZMondelez International, Inc.Open-market sale · 10b5-1 plan | SELL | $7.37M 108.4K sh | Nov 6, 2026 traded Nov 4, 2026 |
| 17 | Pitigoi CosminChief Financial Officer | FLYWFlywire Corp Open-market sale · 10b5-1 plan | SELL | $301K 13.9K sh | Nov 6, 2026 traded Nov 4, 2026 |
| 17 | Saba Capital Management, L.P.10% Owner | PDXPIMCO Dynamic Income Strategy Fund Open-market sale | SELL | $85K 4,172 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 17 | McCulloch KevinSee Remarks |  XERSXeris Biopharma Holdings, Inc.Open-market sale · 10b5-1 plan | SELL | $312K 25.0K sh | Nov 6, 2026 traded Nov 5, 2026 |
| 17 | Chatterjee WhitneyChief Legal Officer |  APOApollo Global Management, Inc.Open-market sale | SELL | $41K 339 sh | Nov 6, 2026 traded Nov 4, 2026 |
| 17 | O'Day Daniel PatrickDirector, Chairman & CEO |  GILDGILEAD SCIENCES, INC.Open-market sale · 10b5-1 plan | SELL | $17.98M 102.6K sh | Nov 6, 2026 traded Nov 4, 2026 |
| 17 | Brown Tice10% Owner |  EMPDEmpery Digital Inc.Open-market sale | SELL | $1,193 500 sh | Nov 6, 2026 traded Nov 4, 2026 |
| 16 | Rothblatt Martine ADirector, Chairperson & CEO |  UTHRUNITED THERAPEUTICS CorpOpen-market sale · 10b5-1 plan | SELL | $321K 562 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 16 | Rothblatt Martine ADirector, Chairperson & CEO | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $311K 539 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 16 | Dai KunDirector, Chief Executive Officer |  UXINUxin LtdOpen-market purchase · 10b5-1 plan | BUY | $7,216 8,307 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 16 | Rothblatt Martine ADirector, Chairperson & CEO | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $334K 585 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 16 | Rothblatt Martine ADirector, Chairperson & CEO | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $337K 560 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 16 | Rothblatt Martine ADirector, Chairperson & CEO | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $293K 520 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 16 | Rothblatt Martine ADirector, Chairperson & CEO | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $262K 462 sh | Nov 6, 2026 traded Nov 5, 2026 |
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
IBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
BBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K
BCYCBICYCLE THERAPEUTICS PLCOct 2 – Oct 56 insiders$63K